Aulitzky, W.E. et al., Recombinant interferon beta in chronic myelogenous leukemia, Sem. Hemat. 30, pp. 14-16 (1993). |
Basso, P. and Verdi, F., Trattamento con beta-interferone nelle infezioni da HPV dell'apparato genitale femminile, Minerva Ginecol. 44, pp. 181-184 (1992) (Abstract in English). |
Cimino, T. et al., Forme istologiche di epatite cronica e risposta al trattamento con interferoni, Minerva Med 84, pp. 681-685 (1993) (Abstract in English). |
Duggan, D.B. et al., A phase II study of recombinant interleukin-2 with or without recombinant interferon-.beta. in non-Hodgkins lymphoma. A study of the cancer and Leukemia group B, Journal of Immunotherapy 12, pp. 115-122 (1992). |
Gomi, K. et al., Antitumor effect of human recombinant interferon-.lambda. and .beta. against human osteosarcoma transplanted into nude mice, J. Pharmacobio-Dyn. 9, pp. 879-888 (1986). |
Gresser, I., Pronounced Antiviral Activity of Human Interferon on Bovine and Porcine Cells, Nature, 251, pp. 543-545 (1974). |
Hertzog, Paul J., et al., Role of Interferons in the Regulation of Cell Proliferation, Differentiation, and Development, Molecular Reproduction and Development, 39, pp. 226-232 (1994). |
Higgins, P.G. et al., Interferon-.beta..sub.ser as phrophylaxis against experimental rhinovirus infection in volunteers, Journal of Interferon Research 6, pp. 153-159 (1986). |
Horoszewicz, J.S. et al., Human Fibroblast Interferon in Human Neoplasia: Clinical and Laboratory Study, Cancer Treatment Reports, 62, pp. 1899-1906 (1978). |
Jacobs, L.D. Intramuscular Interferon Beta-la For Disease Progression in Relapsing Multiple Sclerosis, Annals of Neurology, 39(3), pp. 285-294 (1996). |
Kinney, P. et al., Phase II trial of Interferon-beta-serine in metastatic renal cell carcinoma, J. Clin. Oncol. 8, pp. 881-885 (1990). |
Kunder, S.C. et al., Biological response modifier-mediated resistance to herpesvirus infections requires induction of .alpha./.beta. interferon, Antiviral Research 21, pp. 129-139 (1993). |
Nemato, T. et al., Human Interferons and Intralesional Therapy of Melanoma and Breast Carcinoma (Proceedings of AACR and ASCO), Abstract 993, p. 246. |
Ohno, R., Interferons in the treatment of multiple myeloma, Int. J. Cancer Suppl. 1, pp. 14-20 (1987). |
Ozzello, L. et al., Antiproliferative effects of natural interferon beta alone and in combination with natural interferon gamma on breast carcinomas in nude mice, Breast Cancer Research 16, pp. 89-96 (1990). |
Paty, D.W. et al., Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, Neurology 43, pp. 662-667 (1993). |
Schmidt, C.A. et al., Detection of allelic loss within .beta.1-interferon gene in childhood acute lymphoblastic leukemial using differential PCR, Ann. Hemat. 68, pp. 171-174 (1994). |
Shephard, H. Michael, et al., A Single Amino Acid Change in IFN-.beta..sub.1 Abolishes its Antiviral Activity, Nature, 294, pp. 563-565 (Dec. 1981). |
Sica, G. et al., Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells, Cancer 60, pp. 2419-2423 (1987). |
Stuzziero, E. and Corbo, M., I1 beta interferone nella pratica clinica, Minerva Ginecol. 46, pp. 487-489 (1994) (Abstract in English). |
Stuart-Harris, R.C. et al., The clinical application of the interferons: a review, The Medical Journal of Australia 156, pp. 869-872 (1992). |
Torigoe, S. et al., Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins, Journal of Virological Methods 45, pp. 219-228 (1993). |
Wiernik, P.H. et al., Successful treatment of Hairy Cell Leukemia with .beta.-ser interferon, American Journal of Hematology 33, pp. 244-248 (1990). |
Winkler, K. et al., Treatment of osteosarcoma: Experience of the cooperative osteosarcoma study group (COSS), Osteosarcoma in adolescents and young adults, Cancer treatment and Research 62, pp. 269-277 (1993). |
Wintergerst, U. and Belohradsky, B.H., Acyclovir monotherapy versus Acyclovir plus Beta-Interferon in focal viral encaphalitis in children, Infection 20, pp. 207-212 (1992). |
Worm, M. et al., Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype, Melanoma Research 3, pp. 29-33 (1993). |
Wu, S. et al., A study on the relationship between the N terminal variation of human interferon .beta. and its antiviral activity, Immunochemistry 109, p. 515 (1988) (abstract only). |
Yung, W.K.A., et al., A pilot study of recombinant interferon beta (IFN-.beta..sub.ser) in patients with recurrent glioma, Journal of Neuro-Oncology 9, pp. 29-34 (1990). |
The Houston Chronicle, May 28, 1996. "Patients Suffering from MS Now Have Second Drug Option". |
The New York Times, May 18, 1996. "F.D.A. Approves a Biogen Drug for Treating Multiple Sclerosis". |
Wall Street Journal, May 20, 1996. "New Drug Aims to Win Over MS Sufferers". |
USA Today, May 20, 1996. "Second MS Drug Now On the Market". |